Docoh
Loading...

KPTI Karyopharm Therapeutics

APP
Utility
Substituted Benzofuranyl and Benzoxazolyl Compounds and Uses Thereof
30 Dec 21
Erkan Baloglu, Sharon Shacham, William Senapedis, Dilara McCauley, Yosef Landesman, Gali Golan, Ori Kalid, Sharon Shechter
Filed: 18 Mar 21
APP
Utility
the Combination of XPO1 Inhibitors and Second Agents for the Treatment of Prostate Cancer
14 Oct 21
Erkan Baloglu
Filed: 5 Sep 19
GRANT
Utility
Nuclear transport modulators and uses thereof
21 Sep 21
Erkan Baloglu, Sharon Shacham, Dilara McCauley, Trinayan Kashyap, William Senapedis, Yosef Landesman, Gali Golan, Ori Kalid, Sharon Shechter
Filed: 23 Jul 19
GRANT
Utility
Polymorphs of selinexor
3 Aug 21
The present invention relates to crystalline forms of the compound represented by Structural Formula I, and compositions comprising crystalline forms of the compound represented by Structural Formula I described herein.
Brian C. Austad, David G. Roe
Filed: 11 Nov 19
GRANT
Utility
Hydrazide containing nuclear transport modulators and uses thereof
15 Jun 21
Vincent P. Sandanayaka, Sharon Shacham, Dilara McCauley, Sharon Shechter
Filed: 26 Nov 19
GRANT
Utility
Substituted benzofuranyl and benzoxazolyl compounds and uses thereof
18 May 21
Erkan Baloglu, Sharon Shacham, William Senapedis, Dilara McCauley, Yosef Landesman, Gali Golan, Ori Kalid, Sharon Shechter
Filed: 10 Jul 19
GRANT
Utility
Multicyclic compounds and uses thereof
7 Dec 20
The present invention relates to multicyclic compounds containing a urea or a guanidine moiety, or pharmaceutically acceptable salts or compositions thereof represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the multicyclic compounds.
Erkan Baloglu
Filed: 28 Dec 16
APP
Utility
Hydrazide Containing Nuclear Transport Modulators and Uses Thereof
28 Oct 20
Vincent P. Sandanayaka, Sharon Shacham, Dilara McCauley, Sharon Shechter
Filed: 25 Nov 19
APP
Utility
Polymorphs of Selinexor
9 Sep 20
The present invention relates to crystalline forms of the compound represented by Structural Formula I, and compositions comprising crystalline forms of the compound represented by Structural Formula I described herein.
Brian C. Austad, David G. Roe
Filed: 10 Nov 19
GRANT
Utility
Nuclear transport modulators and uses thereof
13 Jul 20
Erkan Baloglu
Filed: 29 Dec 16
APP
Utility
Nuclear Transport Modulators and Uses Thereof
24 Jun 20
Erkan Baloglu, Sharon Shacham, Dilara McCauley, Trinayan Kashyap, William Senapedis, Yosef Landesman, Gali Golan, Ori Kalid, Sharon Shechter
Filed: 22 Jul 19
APP
Utility
Substituted Benzofuranyl and Benzoxazolyl Compounds and Uses Thereof
1 Apr 20
Erkan Baloglu, Sharon Shacham, William Senapedis, Dilara McCauley, Yosef Landesman, Gali Golan, Ori Kalid, Sharon Shechter
Filed: 9 Jul 19
APP
Utility
Nuclear Transport Modulators and Uses Thereof
18 Mar 20
Vincent P. Sandanayaka, Sharon Shacham, Michael Kauffman, Sharon Shechter, Dilara McCauley, Yosef Landesman, William Senapedis, Jean-Richard Saint-Martin
Filed: 24 Apr 19
GRANT
Utility
Hydrazide containing nuclear transport modulators and uses thereof
27 Jan 20
Vincent P. Sandanayaka, Sharon Shacham, Dilara McCauley, Sharon Shechter
Filed: 27 Nov 18
GRANT
Utility
Nuclear transport modulators and uses thereof
6 Jan 20
Erkan Baloglu
Filed: 29 Dec 16
GRANT
Utility
Polymorphs of Selinexor
30 Dec 19
The present invention relates to crystalline forms of the compound represented by Structural Formula I, and compositions comprising crystalline forms of the compound represented by Structural Formula I described herein.
Brian C. Austad, David G. Roe
Filed: 13 Aug 15
APP
Utility
Hydrazide Containing Nuclear Transport Modulators and Uses Thereof
30 Oct 19
Vincent P. Sandanayaka, Sharon Shacham, Dilara McCauley, Sharon Shechter
Filed: 27 Nov 18
  • 1
Patents are sorted by USPTO publication date, most recent first